Drug-Drug Interaction Potential with Once-Weekly Isoniazid/Rifapentine (3HP) for the Treatment of Latent Tuberculosis Infection
Details
Serval ID
serval:BIB_C29D0A2BD9DD
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Drug-Drug Interaction Potential with Once-Weekly Isoniazid/Rifapentine (3HP) for the Treatment of Latent Tuberculosis Infection
Journal
Clin Pharmacokinet
ISSN
1179-1926 (Electronic)
ISSN-L
0312-5963
Publication state
Published
Issued date
03/2022
Peer-reviewed
Oui
Volume
61
Number
3
Pages
339-346
Language
english
Notes
Marzolini, Catia
Gibbons, Sara
van Oosterhout, Joep J
Khoo, Saye
eng
G0901364/MRC_/Medical Research Council/United Kingdom
MR/V020498/1/MRC_/Medical Research Council/United Kingdom
Switzerland
Clin Pharmacokinet. 2022 Mar;61(3):339-346. doi: 10.1007/s40262-021-01098-8. Epub 2021 Dec 14.
Gibbons, Sara
van Oosterhout, Joep J
Khoo, Saye
eng
G0901364/MRC_/Medical Research Council/United Kingdom
MR/V020498/1/MRC_/Medical Research Council/United Kingdom
Switzerland
Clin Pharmacokinet. 2022 Mar;61(3):339-346. doi: 10.1007/s40262-021-01098-8. Epub 2021 Dec 14.
Keywords
Antitubercular Agents/adverse effects, Drug Interactions, Drug Therapy, Combination, Humans, *Isoniazid/therapeutic use, *Latent Tuberculosis/drug therapy, Rifampin/analogs & derivatives/therapeutic use
Pubmed
Create date
25/08/2023 6:17
Last modification date
27/08/2023 7:01
Usage data
